Benign familial hematuria due to mutation of the type IV collagen alpha 4 gene

被引:149
作者
Lemmink, HH
Nillesen, WN
Mochizuki, T
Schroder, CH
Brunner, HG
vanOost, BA
Monnens, LAH
Smeets, HJM
机构
[1] UNIV LIMBURG,DIV GENET,NL-6201 BL MAASTRICHT,NETHERLANDS
[2] UNIV NIJMEGEN HOSP,DEPT PEDIAT,NL-6500 HB NIJMEGEN,NETHERLANDS
[3] UNIV NIJMEGEN HOSP,DEPT HUMAN GENET,NL-6500 HB NIJMEGEN,NETHERLANDS
[4] ALBERT EINSTEIN COLL MED,DEPT MED,DIV NEPHROL,BRONX,NY 10467
[5] UNIV UTRECHT,DEPT CLIN SCI COMPAN ANIM,UTRECHT,NETHERLANDS
关键词
D O I
10.1172/JCI118893
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Benign familial hematuria (BFH) is characterized by autosomal dominant inheritance, thinning of the glomerular basement membrane (GEM) and normal renal function. It is frequent in patients with persistent microscopic hematuria, but cannot be clinically differentiated from the initial stages of Alport syndrome, a severe GEM disorder which progresses to renal failure, We present here linkage of benign familial hematuria with the COL4A3 and COL4A4 genes at 2q35-37 (Z(max) = 3.58 at theta = 0.0), Subsequently, a glycine to glutamic acid substitution was identified in the collagenous region of the COL4A4 gene, We conclude that type IV collagen defects cause both benign hematuria and Alport syndrome. Furthermore, our data suggest that BFH patients can be carriers of autosomal recessive Alport syndrome.
引用
收藏
页码:1114 / 1118
页数:5
相关论文
共 21 条
[21]  
SPEAR GS, 1972, AM J PATHOL, V69, P213